Results 221 to 230 of about 294,895 (335)

Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy Clinic may improve outcomes and prevent progression to advanced heart failure.
Chandu Sadasivan   +12 more
wiley   +1 more source

Opioid use in Latin America: Chronicle of a death foretold? [PDF]

open access: yesJ Glob Health
León PJ   +4 more
europepmc   +1 more source

A History of Latin America [PDF]

open access: bronze, 1929
Lillian Estelle Fisher
openalex   +1 more source

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high‐, middle‐ and low‐income countries – A Global Congestive Heart Failure (G‐CHF) study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Aims The aim of this study was to describe the prognostic importance of left ventricular ejection fraction (LVEF) versus right ventricular (RV) dilatation and dysfunction in patients with heart failure (HF) from countries of different income levels. Methods and results We enrolled 17 321 participants with HF from 40 countries.
Darryl P. Leong   +16 more
wiley   +1 more source

Biobanking for health in Latin America: a call to action. [PDF]

open access: yesLancet Reg Health Am
Rivera-Alcántara JA   +2 more
europepmc   +1 more source

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

open access: yesEuropean Journal of Heart Failure, EarlyView.
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors   +12 more
wiley   +1 more source

Teaching oral and maxillofacial pathology and oral medicine in undergraduate and postgraduate in Latin America. [PDF]

open access: yesMed Oral Patol Oral Cir Bucal
Trezena-Costa S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy